Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Internal Medicine Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Nephrol Dial Transplant. 2023 Sep 29;38(10):2201-2212. doi: 10.1093/ndt/gfad033.
Prior studies on the association of estimated glomerular filtration rate (eGFR) and mortality have failed to include methods to account for repeated eGFR determinations. The aim of this study was to estimate the association between eGFR and mortality in the general population in Iceland employing a joint model.
We obtained all serum creatinine and urine protein measurements from all clinical laboratories in Iceland in the years 2008-16. Clinical data were obtained from nationwide electronic medical records. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation and categorized as follows: 0-29, 30-44, 45-59, 60-74, 75-89, 90-104 and >104 mL/min/1.73 m2. A multiple imputation method was used to account for missing urine protein data. A joint model was used to assess risk of all-cause mortality.
We obtained 2 120 147 creatinine values for 218 437 individuals, of whom 84 364 (39%) had proteinuria measurements available. Median age was 46 (range 18-106) years and 47% were men. Proteinuria associated with increased risk of death for all eGFR categories in persons of all ages. In persons ≤65 years, the lowest risk was observed for eGFR of 75-89 mL/min/1.73 m2 without proteinuria. For persons aged >65 years, the lowest risk was observed for eGFR of 60-74 mL/min/1.73 m2 without proteinuria. eGFR of 45-59 mL/min/1.73 m2 without proteinuria did not associate with increased mortality risk in this age group. eGFR >104 mL/min/1.73 m2 associated with increased mortality.
These results lend further support to the use of age-adapted eGFR thresholds for defining chronic kidney disease. Very high eGFR needs to be studied in more detail with regard to mortality.
先前关于估算肾小球滤过率(eGFR)与死亡率之间关联的研究未能包括用于解释重复 eGFR 测定的方法。本研究的目的是使用联合模型评估冰岛普通人群中 eGFR 与死亡率之间的关联。
我们获取了 2008-16 年间冰岛所有临床实验室的所有血清肌酐和尿蛋白测量值。临床数据来自全国性电子病历。使用慢性肾脏病流行病学合作方程计算 eGFR,并分为以下几类:0-29、30-44、45-59、60-74、75-89、90-104 和 >104 ml/min/1.73 m2。采用多重插补法解释尿蛋白数据缺失的问题。使用联合模型评估全因死亡率风险。
我们共获得了 218437 名个体的 2120147 个肌酐值,其中 84364 名(39%)有蛋白尿测量值。中位年龄为 46 岁(范围 18-106 岁),47%为男性。在所有年龄段的个体中,所有 eGFR 类别均伴有蛋白尿与死亡风险增加相关。在≤65 岁的个体中,无蛋白尿且 eGFR 为 75-89 ml/min/1.73 m2 时风险最低。对于>65 岁的个体,无蛋白尿且 eGFR 为 60-74 ml/min/1.73 m2 时风险最低。无蛋白尿且 eGFR 为 45-59 ml/min/1.73 m2 时,在该年龄组中与死亡率风险增加无关。eGFR>104 ml/min/1.73 m2 与死亡率增加相关。
这些结果进一步支持使用年龄适应的 eGFR 阈值来定义慢性肾脏病。需要更详细地研究非常高的 eGFR 与死亡率之间的关系。